GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » PT Pyridam Farma Tbk (ISX:PYFA) » Definitions » Total Equity

PT Pyridam Farma Tbk (ISX:PYFA) Total Equity : Rp1,199,071 Mil (As of Sep. 2024)


View and export this data going back to 2001. Start your Free Trial

What is PT Pyridam Farma Tbk Total Equity?

PT Pyridam Farma Tbk's total equity for the quarter that ended in Sep. 2024 was Rp1,199,071 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.


PT Pyridam Farma Tbk Total Equity Historical Data

The historical data trend for PT Pyridam Farma Tbk's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PT Pyridam Farma Tbk Total Equity Chart

PT Pyridam Farma Tbk Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 124,725.99 157,631.75 167,100.57 442,357.49 357,059.70

PT Pyridam Farma Tbk Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 396,854.21 357,059.70 311,743.05 1,349,980.00 1,199,071.00

PT Pyridam Farma Tbk Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

PT Pyridam Farma Tbk's Total Equity for the fiscal year that ended in Dec. 2023 is calculated as

Total Equity=Total Assets(Q: Dec. 2023 )-Total Liabilities(Q: Dec. 2023 )
=1521232.66-1164172.956
=357,060

PT Pyridam Farma Tbk's Total Equity for the quarter that ended in Sep. 2024 is calculated as

Total Equity=Total Assets(Q: Sep. 2024 )-Total Liabilities(Q: Sep. 2024 )
=5892993-4693922
=1,199,071

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


PT Pyridam Farma Tbk Total Equity Related Terms

Thank you for viewing the detailed overview of PT Pyridam Farma Tbk's Total Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


PT Pyridam Farma Tbk Business Description

Traded in Other Exchanges
N/A
Address
Jl. Gen. Sudirman No. Kav. 21, Sinarmas MSIG Tower 12th Floor, RT.10/RW.1, Kuningan, Karet, Setiabudi District, South Jakarta City, Jakarta, IDN, 12920
PT Pyridam Farma Tbk is an Indonesia-based company, engaged in the production and development of pharmaceutical medicines and the trading of medical equipment. It manufactures products namely Antibiotics, Vitamins, Supplements, and Traditional herbal care. It operates through the following segments: Pharmaceutical Products and Toll Manufacturing Services; and Medical Device Products. The company derives maximum revenue from Pharmaceutical Products and Toll Manufacturing Services. The company's products include consumer health, Derma, prescription, and biomedilab.

PT Pyridam Farma Tbk Headlines

No Headlines